The Effect of Dialysis Modality and Membrane Performance on Native Immunity in Dialysis Patients

Efthymios, Pappas M.; Spiridoula, Mpournaka; Periklis, Katopodis; Andreas, Chardalias; Sotiris, Tsakas; Theodoros, Eleftheriadis; Evangelos, Papachristou; Konstantinos, Katopodis P.; Dimitrios, Goumenos S.

doi:10.2478/prilozi-2019-0011

Abstract

Chronic Kidney Disease (CKD) is characterized by immune activation with development of chronic inflammation. However, immune deficiency also exists in CKD patients. The number and the activity of Natural Killer cells (NK-cells) are influenced by the biocompatibility of various dialysis membranes. In this study we investigated the effect of dialysis modality and membrane type on NK-cell number and on phagocytic activity of neutrophils in patients on different dialysis methods.

Sixty patients were included in the study and divided in three groups of 20 patients each. Patients on conventional hemodialysis using Low Flux membrane (cHD-LF) were included in Group I, patients on conventional dialysis using High Flux membrane (cHD-HF) were included in Group II and patients treated by on-line hemodiafiltration with High Flux polysulphone membrane (on-line HDF) were included in Group III. Native immunity was investigated using the number of NK-cells and the phagocytic activity of neutrophils.

NK-cells count was significantly lower (p<0.001) in the three groups of dialyzed patients in comparison to healthy subjects. However, no significant difference was observed in the NK-cells count among patients treated by conventional dialysis using Low or High Flux membrane and patients treated by on-line hemodiafiltration. Similarly, although the phagocytic activity of neutrophils was significantly decreased in all patients on dialysis (p<0.001), no difference related to the dialysis modality or membrane performance was observed. A strong positive correlation was recognized between parathormone blood levels and number of NK-cells (r=0.305, p<0.01).

In conclusion, an impairment of the native immunity represented by NK cell number and phagocytic activity of neutrophils is observed in patients on dialysis. Dialysis modality and membrane performance do not influence the native immunity of dialyzed patients. However, parathormone blood levels are possibly involved in the development of immune system disturbances in such patients.

References

1. Vaziri, N. D.; Pahl, M. V; Crum, A.; Norris, K. Effect of uremia on structure and function of immune system. J. Ren. Nutr. 2012; 22: 149–156, doi:10.1053/j.jrn.2011.10.020.10.1053/j.jrn.2011.10.020
Open DOI Search in Google Scholar Back to article
2. Pahl, M. V; Gollapudi, S.; Sepassi, L.; Gollapudi, P.; Elahimehr, R.; Vaziri, N. D. Effect of end-stage renal disease on B-lymphocyte sub-populations, IL-7, BAFF and BAFF receptor expression. Nephrol. Dial. Transplant 2010; 25: 205–212, doi:10.1093/ndt/gfp397.10.1093/ndt/gfp397
Open DOI Search in Google Scholar Back to article
3. Knerr, K.; Futh, R.; Hemsen, P.; Mohne, W.; Heinig, A.; Kleophas, W.; Scherbaum, W. A.; Martin, S. Chronic inflammation and hemodialysis reduce immune competence of peripheral blood leukocytes in end-stage renal failure patients. Cytokine 2005; 30: 132–138, doi:10.1016/j.cyto.2004.12.011.10.1016/j.cyto.2004.12.01115826820
Open DOI Search in Google Scholar Back to article
4. Kay, N. E. Natural killer cells. Crit. Rev. Clin. Lab. Sci. 1986; 22: 343–359.241903410.3109/10408368509165790
Open DOI Search in Google Scholar Back to article
5. Bender, B. S.; Curtis, J. L.; Nagel, J. E.; Chrest, F. J.; Kraus, E. S.; Briefel, G. R.; Adler, W. H. Analysis of immune status of hemodialyzed adults: association with prior transfusions. Kidney Int. 1984; 26: 436–443.10.1038/ki.1984.193
Open DOI Search in Google Scholar Back to article
6. Raij, L.; Kay, N. E. Effect of hemodialysis membranes on human lymphocyte natural killer function. Contrib. Nephrol. 1987; 59: 17–25.10.1159/000414611
Search in Google Scholar Back to article
7. Kay, N. E.; Raij, L. Differential effect of hemodialysis membranes on human lymphocyte natural killer function. Artif. Organs 1987; 11: 165–167.10.1111/j.1525-1594.1987.tb02651.x
Open DOI Search in Google Scholar Back to article
8. Cala, S.; Mazuran, R.; Kordic, D. Negative effect of uraemia and cuprophane haemodialysis on natural killer cells. Nephrol. Dial. Transplant 1990; 5: 437–440.212232010.1093/ndt/5.6.437
Search in Google Scholar Back to article
9. Zaoui, P.; Hakim, R. M. Natural killer-cell function in hemodialysis patients: effect of the dialysis membrane. Kidney Int. 1993; 43: 1298–1305.831594210.1038/ki.1993.182
Open DOI Search in Google Scholar Back to article
10. Gascon, A.; Orfao, A.; Lerma, J. L.; Ciudad, J.; Lopez, A.; Hernandez, M. D.; Tabernero, J. M. Antigen phenotype and cytotoxic activity of natural killer cells in hemodialysis patients. Am. J. Kidney Dis. 1996; 27: 373–379.860470610.1016/S0272-6386(96)90360-1
Search in Google Scholar Back to article
11. Vacher-Coponat, H.; Brunet, C.; Lyonnet, L.; Bonnet, E.; Loundou, A.; Sampol, J.; Moal, V.; Dussol, B.; Brunet, P.; Berland, Y.; Dignat-George, F.; Paul, P. Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients. Nephrol. Dial. Transplant 2008; 23: 1406-1414, doi:10.1093/ndt/gfm596.10.1093/ndt/gfm59618029366
Open DOI Search in Google Scholar Back to article
12. Griveas, I.; Visvardis, G.; Fleva, A.; Papadopoulou, D.; Mitsopoulos, E.; Kyriklidou, P.; Manou, E.; Ginikopoulou, E.; Meimaridou, D.; Paulitou, A.; Sakellariou, G. Comparative analysis of immunophenotypic abnormalities in cellular immunity of uremic patients undergoing either hemodialysis or continuous ambulatory peritoneal dialysis. Ren. Fail. 2005; 27: 279–282.10.1081/JDI-56620
Search in Google Scholar Back to article
13. Degiannis, D.; Czarnecki, M.; Donati, D.; Homer, L.; Eisinger, R. P.; Raska, K. J.; Raskova, J. Normal T lymphocyte function in patients with end-stage renal disease hemodialyzed with “high-flux” polysulfone membranes. Am. J. Nephrol. 1990; 10: 276–282, doi:10.1159/000168120.10.1159/0001681202240054
Search in Google Scholar Back to article
14. Canaud, B.; Chenine, L.; Henriet, D.; Leray, H. Online hemodiafiltration: a multipurpose therapy for improving quality of renal replacement therapy. Contrib. Nephrol. 2008; 161: 191–198, doi:10.1159/000130677.10.1159/00013067718451677
Open DOI Search in Google Scholar Back to article
15. Daugirdas, J. T.; Depner, T. A.; Gotch, F. A.; Greene, T.; Keshaviah, P.; Levin, N. W.; Schulman, G. Comparison of methods to predict equilibrated Kt/V in the HEMO Pilot Study. Kidney Int. 1997; 52: 1395–1405.10.1038/ki.1997.4679350665
Search in Google Scholar Back to article
16. Deenitchina, S. S.; Ando, T.; Okuda, S.; Kinukawa, N.; Hirakata, H.; Nagashima, A.; Fujishima, M. Cellular immunity in hemodialysis patients: a quantitative analysis of immune cell subsets by flow cytometry. Am. J. Nephrol. 1995; 15: 57–65, doi:10.1159/000168802.10.1159/0001688027872366
Open DOI Search in Google Scholar Back to article
17. Peraldi, M.-N.; Berrou, J.; Metivier, F.; Toubert, A. Natural killer cell dysfunction in uremia: the role of oxidative stress and the effects of dialysis. Blood Purif. 2013, 35 Suppl 2, 14–19, doi:10.1159/000350839.10.1159/00035083923676830
Open DOI Search in Google Scholar Back to article
18. Renaux, J. L.; Thomas, M.; Crost, T.; Loughraieb, N.; Vantard, G. Activation of the kallikrein-kinin system in hemodialysis: role of membrane electronegativity, blood dilution, and pH. Kidney Int. 1999; 55: 1097–1103, doi:10.1046/j.1523-1755.1999.0550031097.x.10.1046/j.1523-1755.1999.0550031097.x10027949
Open DOI Search in Google Scholar Back to article
19. Alexiewicz, J. M.; Smogorzewski, M.; Fadda, G. Z.; Massry, S. G. Impaired phagocytosis in dialysis patients: studies on mechanisms. Am. J. Nephrol. 1991; 11: 102–111, doi:10.1159/000168284.10.1159/0001682841951470
Open DOI Search in Google Scholar Back to article
20. Ballen, K. K.; Shpall, E. J.; Avigan, D.; Yeap, B. Y.; Fisher, D. C.; McDermott, K.; Dey, B. R.; Attar, E.; McAfee, S.; Konopleva, M.; Antin, J. H.; Spitzer, T. R. Phase I trial of parathyroid hormone to facilitate stem cell mobilization. Biol. Blood Marrow Transplant. 2007; 13: 838-843, doi:10.1016/j.bbmt.2007.03.007.10.1016/j.bbmt.2007.03.00717580262
Open DOI Search in Google Scholar Back to article
21. Yamamoto, I.; Potts Jr, J. T.; Segre, G. V Circulating bovine lymphocytes contain receptors for parathyroid hormone. J. Clin. Invest. 1983; 71: 404-407, doi:10.1172/JCI110784.10.1172/JCI110784
Open DOI Search in Google Scholar Back to article
22. Klinger, M.; Alexiewicz, J. M.; Linker-Israeli, M.; Pitts, T. O.; Gaciong, Z.; Fadda, G. Z.; Massry, S. G. Effect of parathyroid hormone on human T cell activation. Kidney Int. 1990; 37: 1543–1551.10.1038/ki.1990.1471972968
Search in Google Scholar Back to article
23. Geara, A. S.; Castellanos, M. R.; Bassil, C.; Schuller-Levis, G.; Park, E.; Smith, M.; Goldman, M.; Elsayegh, S. Effects of parathyroid hormone on immune function. Clin. Dev. Immunol. 2010, 2010, doi:10.1155/2010/418695.10.1155/2010/418695294564820886005
Open DOI Search in Google Scholar Back to article
24. Ozdemir, F. N.; Yakupoglu, U.; Turan, M.; Arat, Z.; Karakayali, H.; Erdal, R.; Turan, M. Role of parathormone levels on T-cell response in hemodialysis patients. Transplant. Proc. 2002; 34: 2044–2045.10.1016/S0041-1345(02)02846-4
Search in Google Scholar Back to article
25. Angelini, D.; Carlini, A.; Giusti, R.; Grassi, R.; Mei, E.; Fiorini, I.; Mazzotta, L.; Antonelli, A. Parathyroid hormone and T-cellular immunity in uremic patients in replacement dialytic therapy. Artif. Organs 1993; 17: 73–75.10.1111/j.1525-1594.1993.tb00415.x8382471
Search in Google Scholar Back to article

The Effect of Dialysis Modality and Membrane Performance on Native Immunity in Dialysis Patients

Abstract

Paradigm

My account